The program targets early-stage African tech startups with up to $50K seed funding, which aligns with the venture's pre-revenue, pre-incorporation stage and Nigeria-first focus. The founder's regulatory expertise and prescription-drug infrastructure play could be compelling, though the program's general tech focus may not fully leverage the healthtech/regulatory angle.